Clinical Trial Results:
A Phase III, eight week randomised double-blind, double-dummy,
forced titration study to compare the fixed-dose combination tablet of
telmisartan 80 mg plus amlodipine 10 mg versus amlodipine 10 mg
over encapsulated capsules mono-therapy as first line therapy in
patients with type 2 diabetes mellitus and Stage I or II hypertension
Summary
|
|
EudraCT number |
2008-000874-19 |
Trial protocol |
NL ES SK SE |
Global completion date |
18 May 2010
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v2(current) |
This version publication date |
18 Mar 2016
|
First version publication date |
09 Apr 2015
|
Other versions |
v1 |
Version creation reason |
|
Summary report(s) |
Trial Synopsis |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.